Member Info for nomlungu

C7 - these links may explain more about my interest in protein shapes.

https://blast.ncbi.nlm.nih.gov/Blast.cgi

http://www.cellbiol.com/

https://www.rcsb.org/

https://www.wwpdb.org/

https://www.expasy.org/

C7 - I know that. I have some links to SAGMA companies that I am going to explore over the next year

I hope you are able to put on the weight your Oncologist has recommend / hoped for.

this idiot is causing some volatility in my investments - it is usexit whilst we try and do brexit

https://theintercept.com/2018/12/22/keep-your-eyes-on-the-narcissist-donald-trumps-latest-antics-are-driven-by-fear-of-robert-mueller/

Keytruda can be bought as a generic drug?

The balance of these factors means that the Company's revenue in 2018 will be broadly in line with 2017 and materially below market expectation.

Chris Richards, Executive Chairman and Interim CEO of Plant Health Care noted: "While the shortfall against expectations is extremely disappointing, our expectations for sales in 2019 are unchanged. We are very encouraged by progress in the US and Brazil. The shortfall in 2018 does not affect the Board's confidence in the Company becoming cash positive no later than 2020, within our existing cash reserves."

How low will this drop?

Neanderthal DNA - We are only 400 generations since mankind mated with less advanced primates.

https://phys.org/news/2017-02-neanderthal-dna-contributes-human-gene.html

https://en.wikipedia.org/wiki/Codon_usage_bias

https://biologydictionary.net/mrna

Interesting Bloomberg story about China getting new foreign drugs before the rest of the world (bearing in mind SCLP's November attendance of the BioCentury-BayHelix China Healthcare Summit in Shanghai). Maybe I am clutching at straws?

https://www.bloomberg.com/news/articles/2018-12-19/china-drug-regulator-transforms-to-world-s-fastest-within-months?srnd=premium-europe

There is a Fred from Salcombe who has been posting about VAL on twatter:

https://twitter.com/hashtag/valirx?f=tweets&vertical=default&src=refgoogle

Great place to live if you are wealthy

This was posted on the Hardy Oil BB in December 2011 - might amuse some:

Some history on bulletin boards.

Don't be a sucker and be very aware of the dangers of buying shares in a company, from a couple posters on here and ii (check out their history on their recommendations over the last three months).as you will find these posters come onto a b/b and slip in the mention of certain shares that they have already bought into, and give you all the spin, maybe even agreeing with some of your follow up replies, or even congratulating each other on a tip that made them a lot of money, and will take turns in recommending, or ramping each other’s tips, or just maybe they may be the same person with different aliases. As long it is along the line of their short term goals(to get the sp higher) and then when the shares rise high enough, they jump ship, but will still post occasionally so as not to draw attention on this, while at the same time, they will be sitting back laughing at you, and moving onto their next victims. If you’re a day-trader, then following them could make you short term gains, but if you are after a medium term gain, then by not doing your own proper research and following these cretins, you will be greatly disappointed. So I will finish by repeating, that with o/t posts, etc, look at the tip/news, and ask yourselves has this information not already been factored into the price already, or has the information that is being passed on to try and drag you in, not been manipulated in some way, i.e.,(certain parts left out of the bigger picture.)Check their history, no less than three months back, to compare on their recommendations/tip, and compare this with the share price graph, and finally if you still think that maybe this could still be a good company to invest in, after doing your own research, then by all means invest, but I would not invest too much, but keep some finances back when the share price retraces, which usually happens when these posters are long gone and banked their easy profits and moved on to the next suckers.

I have a feeling that a few multi-bag optimists may be feeling a bit queasy now that the reality of 'investing' in Valirx finally takes hold.

They are still authorised to issue over 300 million more shares - could they not get the rest away at 0.75p? I would have considered buying a few if they had issued the lot but the prospect of further dilution dampens any enthusiasm from me for now.

Good luck to any new investors buying in now and of course, to those who feel compelled to average down [again].

RuckRover,

Try searching 'pd-l1 scancell protein'.

Then search this string:

pd-l1 scancell protein rna dna defects

All of my models were based on a share price floor of a penny. If the bid goes lower then I expect the 'potential' placing price to be significantly lower than the 0.65 I had previously modelled.

One last raise of one and a half million quid - thats 0.4p if they issue all of the shares allowed.

Without news, where will this go [are you reading this BOD ?!!!!].

Obviously, my comments are all in my opinions so welcome any facts that I can assess and input into my model.

ratcliffewriter,

I might spend too much time listening to Parliament but trying to blame anyone but the rulers stinks of partisanship.

All I know is that my Pounds are getting worth less.

To me, there is no protein in the Conservatives. They have been in power for close on a decade.

Austerity has not worked and the National Debt has gone awry.

Are we done with her?

Oh, Mrs May, should we pray?

'Still the same old rubbish repeated over and over...'

What rubbish are you referring to?

When will the 15% surge predicted by Brainer happen? Or, is it more likely that further retail news from other vendors will further depress this share?

Retail is getting hammered - even Amazon have diversified with their cloud services.

I do not subscribe to the school of thought that dismissing someone/all from/of the BOD helps with a BIO company like VAL, especially when done by activist investors. You can end up losing key knowledge, especially when detailed succession planning is not in place.

VAL have a Board of Directors, Executive Committee, Management Team, Advisory Board and a Scientific Advisory Board. Thats a lot of seats at the table. I would like to see key employees being contractually obliged to spend at least 15% of what they are paid by VAL buying shares on the open market [gross of tax]. The rest should have to buy a significantly higher percentage, also gross of tax.

Who is first to go / what next? After reading AdamH90's comment I had a look at VAL's structure again - personally, I would like to see a new CFO. The link below shows how many companies he appears to be / have been a director off.

https://beta.companieshouse.gov.uk/search/officers?q=Gerry%20Desler

All in my opinion etc... And, of course, what do I know? Maybe they will provide a Christmas present to shareholders but I fear that the glass they offer shareholders may be half empty.

Why are Alan's posts being removed? He may have a differing opinion to the resident rampers but seems to make many valid points.

It is a bit like Brexiteers refusing a second vote because they are scared...

And how many years has he [along with the rest of the BOD] drawn a salary?

Must be somewhere between 1 and 2 million pounds paid to him so far - many here would say he has been more than amply rewarded for the progress of VAL401 [and the other compounds] to date.